Company: BKYI
Filing Date: 2025-04-23
Form Type: 10-K
Source: 0001437749-25-012824
Chunk: 399

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-23
Form: 10-K
Item: Item 8
Chunk 399
---
 Deferred tax liability   -   22,998 
 Government loan – BBVA Bank, net of current portion   44,762   188,787 
 Operating lease liabilities, net of current portion   48,994   - 
 Total non-current liabilities   289,993   240,081 
 TOTAL LIABILITIES   4,843,529   3,453,470 
         
 Commitments (Note O)           
         
 STOCKHOLDERS’ EQUITY         
 Common stock — authorized, 170,000,000 shares; issued and outstanding; 3,715,483 and 1,032,777 of $.0001 par value at December 31, 2024 and December 31, 2023, respectively   372   103 
 Additional paid-in capital   133,030,271   126,047,851 
 Accumulated other comprehensive loss   49,290   22,821 
 Accumulated deficit   (129,307,902)  (125,007,210)
 TOTAL STOCKHOLDERS’ EQUITY   3,772,031   1,063,565 
 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $8,615,560  $4,517,035 

All BIO-key shares issued and outstanding for all periods reflect BIO-key’s 1-for-18 reverse stock split, which was effective December 21, 2023.

The accompanying notes are an integral part of these statements.

    42

BIO-key International, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

       2024 

       2023 

       Revenues 

       Services 
       
      $
      1,108,506

      $
      2,218,885

       License fees 

      5,189,370

      4,342,010

       Hardware 

      631,695

      1,194,010

       Total revenues 

      6,929,571

      7,754,905

       Costs and other expenses 

       Cost of services 

      396,274

      861,936

       Cost of license fees 

      589,505

      1,174,919

       Cost of hardware 

      516,611